S-adenosylhomocysteine hydrolase
From Proteopedia
(Difference between revisions)
(6 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | <StructureSection load=' | + | <StructureSection load='' size='350' side='right' caption='Structure of rat S-adenosylhomocysteine hydrolase tetramer complex with NAD and adenine (PDB entry [[1xwf]])' scene='55/552186/Cv/1'> |
== Function == | == Function == | ||
'''S-adenosylhomocysteine hydrolase''' (AHCH) converts S-adenosylhomocysteine (AdoHcy) to L-homocysteine and adenosine. AHCH uses NAD+ as cofactor. AHCH is an essential enzyme in processes like transmethylation, trans-sulfuration and purine metabolism<ref>PMID:15488656</ref>. | '''S-adenosylhomocysteine hydrolase''' (AHCH) converts S-adenosylhomocysteine (AdoHcy) to L-homocysteine and adenosine. AHCH uses NAD+ as cofactor. AHCH is an essential enzyme in processes like transmethylation, trans-sulfuration and purine metabolism<ref>PMID:15488656</ref>. | ||
Line 7: | Line 7: | ||
== Structural highlights == | == Structural highlights == | ||
- | The biological assembly of rat S-adenosylhomocysteine hydrolase is <scene name='55/552186/Cv/ | + | The biological assembly of rat S-adenosylhomocysteine hydrolase is <scene name='55/552186/Cv/6'>homotetramer</scene>. AHCH structure contains <scene name='55/552186/Cv/7'>3 domains: catalytic, NAD-binding and C-terminal domain</scene>. The <scene name='55/552186/Cv/8'>active site is located in a cleft between the catalytic domain and the NAD-binding domain and it contains the cofactor NAD and the product adenine</scene><ref>PMID:16061414</ref>. |
</StructureSection> | </StructureSection> | ||
Line 23: | Line 23: | ||
**[[3gvp]] – hAHCH SAHH-like domain + NAD <BR /> | **[[3gvp]] – hAHCH SAHH-like domain + NAD <BR /> | ||
**[[3d64]] – BpAHCH + NAD – ''Burkholderia pseudmallei''<BR /> | **[[3d64]] – BpAHCH + NAD – ''Burkholderia pseudmallei''<BR /> | ||
+ | **[[3x2f]] – AHCH + NADH – ''Thermotoga maritima''<BR /> | ||
*S-adenosylhomocysteine hydrolase complex with adenosine derivatives | *S-adenosylhomocysteine hydrolase complex with adenosine derivatives | ||
Line 37: | Line 38: | ||
**[[3one]] – lAHCH + NAD + adenine <BR /> | **[[3one]] – lAHCH + NAD + adenine <BR /> | ||
**[[3onf]] – lAHCH + NAD + adenosine derivative <BR /> | **[[3onf]] – lAHCH + NAD + adenosine derivative <BR /> | ||
+ | **[[5m66]] – BeAHCH + NAD + adenosine – ''Bradyrhizobium elkanii''<BR /> | ||
+ | **[[5m5k]] – BeAHCH + NAD + adenosine + cordycepin<BR /> | ||
+ | **[[5m67]] – BeAHCH + NAD + adenosine + deoxyadenine<BR /> | ||
+ | **[[3g1u]] – AHCH + NAD + adenosine – ''Leishmania major''<BR /> | ||
+ | |||
+ | *S-adenosylhomocysteine hydrolase other complexes | ||
+ | |||
+ | **[[5w49]], [[5w4b]] – hAHCH + NAD + inhibitor<BR /> | ||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
+ | [[Category:One-carbon metabolism]] |
Current revision
|
3D structures of S-adenosylhomocysteine hydrolase
Updated on 14-November-2023
References
- ↑ Altintas E, Sezgin O. S-adenosylhomocysteine hydrolase, S-adenosylmethionine, S-adenosylhomocysteine: correlations with ribavirin induced anemia. Med Hypotheses. 2004;63(5):834-7. PMID:15488656 doi:http://dx.doi.org/10.1016/j.mehy.2004.03.031
- ↑ Baric I, Fumic K, Glenn B, Cuk M, Schulze A, Finkelstein JD, James SJ, Mejaski-Bosnjak V, Pazanin L, Pogribny IP, Rados M, Sarnavka V, Scukanec-Spoljar M, Allen RH, Stabler S, Uzelac L, Vugrek O, Wagner C, Zeisel S, Mudd SH. S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4234-9. Epub 2004 Mar 15. PMID:15024124 doi:10.1073/pnas.0400658101
- ↑ Yamada T, Takata Y, Komoto J, Gomi T, Ogawa H, Fujioka M, Takusagawa F. Catalytic mechanism of S-adenosylhomocysteine hydrolase: roles of His 54, Asp130, Glu155, Lys185, and Aspl89. Int J Biochem Cell Biol. 2005 Nov;37(11):2417-35. PMID:16061414 doi:10.1016/j.biocel.2005.06.009
Proteopedia Page Contributors and Editors (what is this?)
Michal Harel, Alexander Berchansky, Karsten Theis, Joel L. Sussman